Metraipolis › archive › dc_ed830f39cfcd

Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026 — Europe PMC PMID:41645799

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41645799
DOI: 10.2807/1560-7917.es.2026.31.5.2600068
License (as archived): solo-consultazione
Archived: 2026-11-06T08:59:39.500Z
SHA-256 of the archived text: ae9f5df3b2306b3b6dc12d5267b796dea473906737ccd8c53198e0e2b43898e3
Stable URL of this page: https://metraipolis.com/documento/dc_ed830f39cfcd

How to cite

Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026 — Europe PMC PMID:41645799 — Europe PMC (en), https://europepmc.org/article/MED/41645799 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ed830f39cfcd (Metraipolis archive dc_ed830f39cfcd, sha256 ae9f5df3b2306b3b6dc12d5267b796dea473906737ccd8c53198e0e2b43898e3)

BibTeX

@misc{dced830f39cfcd,
  title = {Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026 — Europe PMC PMID:41645799},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41645799},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ed830f39cfcd; sha256 ae9f5df3b2306b3b6dc12d5267b796dea473906737ccd8c53198e0e2b43898e3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41645799. Agents can read the archived copy with the MCP tool read_document.